1. Home
  2. PRAX vs ENVA Comparison

PRAX vs ENVA Comparison

Compare PRAX & ENVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

HOLD

Current Price

$364.58

Market Cap

7.1B

Sector

Health Care

ML Signal

HOLD

Logo Enova International Inc.

ENVA

Enova International Inc.

HOLD

Current Price

$237.39

Market Cap

5.8B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRAX
ENVA
Founded
2015
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
7.1B
5.8B
IPO Year
2020
2011

Fundamental Metrics

Financial Performance
Metric
PRAX
ENVA
Price
$364.58
$237.39
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
15
7
Target Price
$572.13
$185.71
AVG Volume (30 Days)
401.0K
302.5K
Earning Date
05-08-2026
04-23-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
55.05
EPS
N/A
7.45
Revenue
N/A
$3,151,653,000.00
Revenue This Year
N/A
$149.64
Revenue Next Year
$7,758.26
$16.42
P/E Ratio
N/A
$34.14
Revenue Growth
N/A
18.58
52 Week Low
$37.25
$103.02
52 Week High
$392.45
$267.45

Technical Indicators

Market Signals
Indicator
PRAX
ENVA
Relative Strength Index (RSI) 58.43 44.18
Support Level $291.44 $217.38
Resistance Level N/A $246.38
Average True Range (ATR) 19.51 7.77
MACD 2.70 -2.57
Stochastic Oscillator 76.31 19.40

Price Performance

Historical Comparison
PRAX
ENVA

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

About ENVA Enova International Inc.

Enova International Inc provides online financial services, including short-term consumer loans, line of credit accounts, and installment loans to customers mainly in the United States and Brazil. Consumers apply for credit online, the company's technology platforms process the applications, and transactions are completed quickly and efficiently. Its customers are predominantly retail consumers and small businesses. Enova markets its financing products under the names CashNetUSA, NetCredit, OnDeck, Headway Capital, and Simplic. The company also operates a money transfer platform under the name Pangea. Geographically, the company generates a majority of its revenue from its business in the United States and the rest from other international countries.

Share on Social Networks: